| # | Side effect | Count |
|---|---|---|
| 0 | HOSPITALISATION | 1026 |
| 1 | DEATH | 414 |
| 2 | OFF LABEL USE | 373 |
| 3 | THERAPY INTERRUPTED | 354 |
| 4 | DIARRHOEA | 272 |
| 5 | FATIGUE | 270 |
| 6 | NAUSEA | 249 |
| 7 | PNEUMONIA | 245 |
| 8 | HEADACHE | 183 |
| 9 | COVID-19 | 176 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | SPINAL ARTERY THROMBOSIS | 3 | 0.1111 |
| 1 | CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION | 5 | 0.1111 |
| 2 | RAOULTELLA ORNITHINOLYTICA INFECTION | 8 | 0.1039 |
| 3 | SUBGLOTTIC LARYNGITIS | 2 | 0.0800 |
| 4 | ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED | 13 | 0.0774 |
| 5 | SUSPECTED DRUG-INDUCED LIVER INJURY | 15 | 0.0750 |
| 6 | ABDOMINAL WALL PAIN | 1 | 0.0588 |
| 7 | VANISHING BILE DUCT SYNDROME | 60 | 0.0538 |
| 8 | INTERFERON GAMMA RELEASE ASSAY POSITIVE | 6 | 0.0366 |
| 9 | GRANULOMATOSIS WITH POLYANGIITIS | 43 | 0.0356 |